Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH

Serum LPS and CD163 Biomarkers Confirming the Role of Gut Dysbiosis in Overweight Patients with NASH

Mona A Hegazy,1 Sherif M Mogawer,1 Alshaimaa Rezk L R Alnaggar,1 Olfat A Ghoniem,2 Rasha M Abdel Samie1 1Internal Medicine Department, Kasr Alainy Hospital, Faculty of Medicine, Cairo University, Cairo, Egypt; 2Internal Medicine, Ministry of Health, Cairo, EgyptCorrespondence: Mona A Hegazy Tel +201...

Full description

Bibliographic Details
Main Authors: Hegazy MA, Mogawer SM, Alnaggar ARLR, Ghoniem OA, Abdel Samie RM
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
non-alcoholic steatohepatitis
inflammation
microbiota
cd163
lps.
Online Access:https://www.dovepress.com/serum-lps-and-cd163-biomarkers-confirming-the-role-of-gut-dysbiosis-in-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/serum-lps-and-cd163-biomarkers-confirming-the-role-of-gut-dysbiosis-in-peer-reviewed-article-DMSO

Similar Items